Gamage; Swarnalatha Akuratiya

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gamage; Swarnalatha Akuratiya.The latest application filed is for "inhibitors of tryptophan dioxygenases (ido1 and tdo) and their use in therapy".

Company Profile

5.10.17

Gamage; Swarnalatha Akuratiya - Auckland NZ
Gamage; Swarnalatha Akuratiya - Greenlane NZ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
FGFR kinase inhibitors and pharmaceutical uses Grant 11,192,890 - Patterson , et al. December 7, 2	2021-12-07
Tricyclic heterocyclic derivatives and uses thereof Grant 11,028,064 - Gamage , et al. June 8, 2	2021-06-08
INHIBITORS OF TRYPTOPHAN DIOXYGENASES (IDO1 and TDO) AND THEIR USE IN THERAPY App 20210145839 - Palmer; Brian Desmond ; et al.	2021-05-20
Inhibitors of tryptophan dioxygenases (IDO1 and TDO) and their use in therapy Grant 10,888,567 - Palmer , et al. January 12, 2	2021-01-12
Fgfr Kinase Inhibitors And Pharmaceutical Uses App 20200017491 - PATTERSON; Adam Vorn ; et al.	2020-01-16
Tricyclic Heterocyclic Derivatives And Uses Thereof App 20190276423 - GAMAGE; Swarnalatha Akuratiya ; et al.	2019-09-12
Ketamine Derivatives App 20190169113 - Sleigh; James Wallace ; et al.	2019-06-06
Ketamine derivatives Grant 10,239,825 - Sleigh , et al.	2019-03-26
INHIBITORS OF TRYPTOPHAN DIOXYGENASES (IDO1 and TDO) AND THEIR USE IN THERAPY App 20170224701 - Palmer; Brian Desmond ; et al.	2017-08-10
Ketamine Derivatives App 20170190653 - Sleigh; James Wallace ; et al.	2017-07-06
Ketamine Derivatives App 20150259277 - Sleigh; James Wallace ; et al.	2015-09-17
Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy Grant 9,108,980 - Rewcastle , et al. August 18, 2	2015-08-18
Pyrimidinyl And 1,3,5-triazinyl Benzimidazole Sulfonamides And Their Use In Cancer Therapy App 20150038486 - Rewcastle; Gordon William ; et al.	2015-02-05
Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy Grant 8,772,287 - Rewcastle , et al. July 8, 2	2014-07-08
Pyrimidinyl And 1,3,5-triazinyl Benzimidazole Sulfonamides And Their Use In Cancer Therapy App 20130289016 - Rewcastle; Gordon William ; et al.	2013-10-31
Pyrimidinyl and 1,3,5-triazinyl benzimidazoles and their use in cancer therapy Grant 8,486,939 - Rewcastle , et al. July 16, 2	2013-07-16
Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy Grant 8,461,158 - Rewcastle , et al. June 11, 2	2013-06-11
Substituted Pyrimidines And Triazines And Their Use In Cancer Therapy App 20110053907 - Rewcastle; Gordon William ; et al.	2011-03-03
Pyrimidinyl And 1,3,5-triazinyl Benzimidazoles And Their Use In Cancer Therapy App 20110009405 - Rewcastle; Gordon William ; et al.	2011-01-13
Pyrimidinyl And 1,3,5-triazinyl Benzimidazole Sulfonamides And Their Use In Cancer Therapy App 20100249099 - Rewcastle; Gordon William ; et al.	2010-09-30
Dna-targeted benzotriazine 1,4-dioxides and their use in cancer therapy App 20070191372 - Brown; J. Martin ; et al.	2007-08-16
Benzoazine mono-N-oxides and benzoazine 1,4 dioxides and compositions therefrom for the therapeutic use in cancer treatments App 20040192686 - Wilson, William Robert ; et al.	2004-09-30
Pharmaceutical compounds App 20010034346 - Milton, John ; et al.	2001-10-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.